Skip to main content

Table 3 Aetiology of infections

From: Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcusspp. infection after cerebrospinal fluid diversion procedures

 

Treatment cohort

Control cohort

Total

 

EVD

Shunt

Total

EVD

shunt

total

 

Staphylococcus spp.

2

2

4

7

5

12

16 (55.2%)

S. epidermidis

2

2

4

7

4

11

 

S. aureus

0

0

0

0

1

1

 

GNBs

4

0

4

5

2

7

11 (37.9%)

P. aeruginosa

0

0

0

0

1

1

 

Acinetobacter spp.

2

0

2

1

0

1

 

Enterobacter spp.

1

0

1

1

0

1

 

E. coli

0

0

0

1

0

1

 

Sphingomonas spp.

1

0

1

0

0

0

 

Klebsiella spp.

0

0

0

2

1

3

 

Other microorganisms

4

0

4

3

1

4

8 (27.6%)

Enterococcus spp.

2

0

2

2

0

2

 

Streptococcus spp.

0

0

0

0

1

1

 

Corynebacterium spp.

1

0

1

1

0

1

 

Candida spp.

1

0

1

0

0

0

 

Total (infection per procedure)

6/47 (12.8%)

2/72 (2.7%)

8/119 (6.7%)

13/65 (20%)

8/47 (17%)

21/112 (18.8%)

29/231 (12.6%)

  1. EVD: external ventricular drain